RIVER GLOBAL INVESTORS LLP - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 281 filers reported holding GW PHARMACEUTICALS PLC in Q4 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
RIVER GLOBAL INVESTORS LLP ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2020$3,562,000
+16.1%
36,500
+46.0%
0.26%
+17.9%
Q2 2020$3,069,000
-37.6%
25,000
-55.4%
0.22%
-50.2%
Q1 2020$4,917,000
+8.1%
56,000
+28.7%
0.45%
+78.6%
Q4 2019$4,547,000
-70.7%
43,500
-67.8%
0.25%
-76.9%
Q3 2019$15,518,000
+43.9%
135,000
+116.0%
1.09%
+44.6%
Q2 2019$10,785,000
+19.5%
62,500
+16.8%
0.75%
+19.5%
Q1 2019$9,023,000
+73.4%
53,5000.0%0.63%
+39.7%
Q4 2018$5,204,00053,5000.45%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2018
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders